The dual legacy of Daubert v. Merrell-Dow Pharmaceutical: Trading junk science for insidious science

Rescuing Science from Politics: Regulation and the Distortion of Scientific Research

Volumn , Issue , 2006, Pages 120-142

  Cranor, Carl F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 42149125824     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511751776.010     Document Type: Chapter

References (47)

1. Michael D. Green, Bendectin and Birth Defects: The Challenges of Mass Toxic Substances Litigation (Philadelphia, PA: University ofPennsylvania Press, 1996), 20-1
2. Peter Huber, Galileo's Revenge: Junk Science in the Courtroom [New York: Basic Books, 1991]
3. Peter Huber, Liability: The Legal Revolution and Its Consequences [New York: Basic Books, 1988]).
4. Russellyn S. Carruth and Bernard D. Goldstein, "Relative Risk Greater Than Two in Proof of Causation in Toxic Tort Litigation," Jurimetrics: The Journal of Law, Science, and Technology 41, no. 2 (2001): 200-1
5. Bert Black and David E. Lilienfeld, "Epidemiologic Proof in Toxic Tort Litigation," Fordham Law Review 52, no. 5 (1984): 732, 769.
6. Joe G. Hollingsworth and Eric Lasker, "The Case against Differential Diagnosis: Daubert, Medical Causation Testimony and the Scientific Method," Journal of Health Law 37, no. 1 (2004): 85-112.
7. James Huff and David P. Rall, "Relevance to Humans of Carcinogenesis Results from Laboratory Animal Toxicology Studies," in Maxcy-Rosenau-Last: Public Health and Preventive Medicine, ed. John M. Last and Robert B. Wallace (Norwalk, CT: Appleton and Lange, 13th ed., 1992), 433, 439
8. Lorenzo Tomatis et al., "Avoided and Avoidable Risks of Cancer," Carcinogenesis, 18, no. 1 (1997): 97, 100.
9. Patricia A. Buffler, "Uses of Epidemiology in Environmental Medicine," in Environmental Medicine, ed. Stuart M. Brooks et al. (St. Louis, MO: Mosby, 1995), 46-62, esp. 55.a
10. Robert A. Rinsky et al., "Benzene Exposure and Hematopoietic Mortality: A Long-Term Epidemiological Risk Assessment, American Journal of Industrial Medicine 42, no. 6 (2002): 474-480
11. Sharon R. Silver et al., "Effect of Follow-Up Time on Risk Estimates: A Longitudinal Examination of the Relative Risks of Leukemia and Multiple Myeloma in a Rubber Hydrochloride Cohort," American Journal of Industrial Medicine 42, no. 6 (2002): 481-9.
12. Frederica P. Perera, "Molecular Epidemiology: Insights into Cancer Susceptibility, Risk Assessment, and Prevention," Journal of the National Cancer Institute 88, no. 8 (1996): 496-509
13. Sander Greenland, "Relation of Probability of Causation to Relative Risk and Doubling Dose: A Methodologic Error That Has Become a Social Problem," American Journal of Public Health 89, no. 8 (1999): 1166
14. Sander Greenland and James M. Robins, "Epidemiology, Justice, and the Probability of Causation," Jurimetrics: The Journal of Law, Science, and Technology 40, no. 3 (2000): 321.
15. H. Kato, "Cancer Mortality," in Cancer in Atomic Bomb Survivors, ed. Itsuzo Shigematsu and Abraham Kagan (Tokyo: Japan Scientific Societies Press, 1986)
16. Arthur K. Sullivan, "Classification, Pathogenesis, and Etiology of Neoplastic Diseases of the Hematopoietic System," in G. Richard Lee et al., Wintrobe's Clinical Hematology 2 (Philadelphia, PA: Lea and Febiger, 9th ed., 1993), 1725, 1750.
17. Julius C. McElveen and Chris Amantea, "Legislating Risk Assessment," University of Cincinnati Law Review 63, no. 4 (1995): 1553, 1556.
18. Carl F. Cranor, The Science Veil over Toxic Tort Law (forthcoming)
19. Carl F. Cranor and David A. Eastmond, "Scientific Ignorance and Reliable Patterns of Evidence in Toxic Tort Causation: Is There a Need for Liability Reform?" Journal of Law and Contemporary Problems 64, no. 4 (2001): 42-3.
20. Victor A. Fung et al., "The Carcinogenesis Bioassay in Perspective-Application in Identifying Human Cancer Hazards," Environmental Health Perspectives 103, no. 7-8 (1995): 682
21. Curtis C. Travis, "Interspecies Extrapolation of Toxic Data," in Health Risk Assessment: Dermal and Inhalation Exposure and Absorption of Toxicants, ed. Rhoda G. M. Wang et al. (Boca Raton, FL: CRC Press, 1993), 387-410
22. http://www-cie.iarc.fr/monoeval/preabmle.html
23. David P. Rall et al., "Alternatives to Using Human Experience in Assessing Health Risks," Annual Review of Public Health 8 (1987): 355-6.
24. J. S. Bertram et al., "Rationales and Strategies for Chemoprevention of Cancer in Humans," Cancer Research 47, no. 11(1987): 3012.
25. George M. Gray et al., "An Empirical Examination of Factors Influencing Prediction of Carcinogenic Hazard across Species," Regulatory Toxicology and Pharmacology 22, no. 3 (1995): 283-4, 287.
26. Jerry M. Rice et al., "Rodent Tumors of Urinary Bladder, Renal Cortex, and Thyroid Gland in IARC Monographs Evaluations of Carcinogenic Risk to Humans," Toxicological Sciences 49, no. 2 (1999): 171.
27. Ellen K. Silbergeld, "The Role of Toxicology in Causation: A Scientific Perspective," Courts, Health Science and the Law 1, no. 3 (1991): 374.
28. Carl F. Cranor, "Justice, Inference to the Best Explanation and the Judicial Evaluation of Scientific Evidence," in Topics in Contemporary Philosophy: Vol. III: Law and Social Justice, ed. Joseph Keim Campbell et al. (Cambridge, MA: MIT Press, forthcoming 2005)
29. Carl F. Cranor, "The Science Veil over Toxic Tort Law: How Should Scientific Evidence Be Used in Toxic Tort Law?" Law and Philosophy (forthcoming 2005)
30. Carl F. Cranor, "Scientific Inferences in the Laboratory and the Law," American Journal of Public Health (forthcoming).
31. Bernard D. Goldstein and Mary Sue Henifin, "Reference Guide on Toxicology," in Reference Manual on Scientific Evidence (2nd ed., 2000), 419 (available at http:/www.fjc.gov/public/home.nsf/autoframe?openform&url r=pages/556&url l=index).
32. Thomas O. McGarity, "Our Science Is Sound Science and Their Science Is Junk Science: Science-Based Strategies for Avoiding Accountability and Responsibility for Risk-Producing Products and Activities," University of Kansas Law Review 52 (2004): 897.
33. Gilbert H. Harman, "The Inference to the Best Explanation," Philosophical Review 74, no. 1 (1994): 89-90
34. Paul Thagard, How Scientists Think about Disease (Princeton, NJ: Princeton University Press, 1999), 129
35. Larry Wright, Critical Thinking (New York: Oxford University Press, 2001).
36. Brian Skyrms, Choice and Chance: An Introduction to Inductive Logic (Belmont, CA: Dickenson, 1966).
37. Larry Wright, Practical Reasoning (New York: Harcourt, Brace Jovanovitch, 1989), 104.
38. Tom A. Hutchinson and David A. Lane, "Standardized Methods of Causality Assessment of Suspected Adverse Drug Reactions," Journal of Clinical Epidemiology 42, no. 1 (1989): 10.
39. Samuel M. Cohen, "Alternative Models for Carcinogenicity Testing:Weight of Evidence Evaluations Across Models," Toxicologic Pathology 29, Suppl. (2001): 183-90
40. Allan H. Conney, "Induction of Microsomal Enzymes by Foreign Chemicals and Carcinogenesis by Polycyclic Aromatic Hydrocarbons: G.H.A. Clowes Memorial Lecture," Cancer Research 42, no. 12 (1982): 4875-4917
41. International Agency for Research on Cancer, "Consensus Report: The Use of Short-and Medium-Term Tests for Carcinogens and Data on Genetic Effects in Carcinogenic Hazard Evaluation," IARC Scientific Publications No. 146, ed. D. B. McGregor et al. (1999) (available at http://www-cie.iarc.fr/htdocs/iarcpubs/pub146/pub146contents.html)
42. R. Michael McClain et al., "Neonatal Mouse Model: Review of Methods and Results," Toxicologic Pathology 29, Suppl. (2001): 128-37
43. Miriam C. Poirier, "In Memoriam: James A. Miller (1915-2000)," Carcinogenesis 22, no. 4 (2001): 681-3
44. Henry C. Pitot, III, and Yvonne P. Dragan, "Chemical Carcinogensesis," in Casarett and Doull's Toxicology: The Basic Science of Poisons, ed. Curtis d. Kaassen (New York: McGraw-Hill, 6th ed., 2001), 267, 278.
45. R. Julian Preston and George R. Hoffmann, "Genetic Toxicology," in Casarett and Doull's Toxicology, 342.
46. Joe G. Hollingsworth and Eric Lasker, "The Case against Differential Diagnosis: Daubert, Medical Causation Testimony and the Scientific Method," Journal of Health Law 37, no. 1 (2004): 85-112
47. Margaret A. Berger, "Eliminating General Causation: Notes towards a New Theory of Justice and Toxic Torts," Columbia Law Review 97, no. 7 (1997): 2135